InternationalUSRemember you can easily switch between MIP US and MIP International at any time

GeneDx files 11 IPR petitions against Myriad patents

Michael Loney, New York

Genetic testing company GeneDx has turned to the Patent Trial and Appeal Board to try and invalidate 11 of Myriad Genetics patents, in a move that underlines the increasing popularity of inter partes review proceedings with the pharmaceutical industry

Law firm Sterne Kessler Goldstein & Fox filed 11 petitions for inter partes review (IPR) on behalf of GeneDx, a subsidiary of BioReference Laboratories, aiming to nullify 11 patents owned, co-owned, or licensed by Myriad Genetics.

These patents have been asserted...

Please log in to read the rest of this article.

New to Managing Intellectual Property? Take advantage of free access to up to 5 articles on Managing IP and become a member today. It’s free to join and the benefits start straight away.

Already registered?

Please make sure you log in to read the rest of the article.

Log in

Join us now

Gain FREE access to up to five free articles when you register now.

Join here

More from the Managing IP blog

null null null

null null null


September / October 2019

Should I stay or should I go? Private practice v in-house

In-house or private practice? It’s a question many lawyers and attorneys will probably ask themselves at some stage in their career, as Managing IP finds out

Most read articles